Plain-English translation of NCT06137521 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at patients who have a completely blocked coronary artery (a blood vessel supplying the heart) that has been blocked for at least 3 months. Researchers want to understand what factors affect how well patients do over time, including whether the body naturally develops alternate blood vessels to bypass the blockage. By studying these patterns, doctors hope to make better decisions about treatment options.
Patients with completely blocked heart arteries tend to have worse outcomes than those without complete blockages. However, some patients do better than others depending on various factors that doctors don't fully understand yet. This research aims to identify which characteristics—including blood test results and how well the body develops alternate blood pathways—can predict who will have better or worse outcomes, so doctors can personalize treatment decisions.
You likely qualify if…
You likely don't qualify if…
This is an observational study, meaning you will not receive a new medication—instead, researchers will gather information about your condition and health over time. You will have blood samples collected, and your medical history and test results will be reviewed and recorded. The study will track how you do based on whether your body has developed good or poor alternate blood vessels around the blockage, helping researchers understand what factors are most important for your long-term health.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
China
Sponsor
Ruijin Hospital
Enrollment target
~3,000 participants
Started
January 2010
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Fenghua Ding, PhD, MD
Ruijin Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.